BMRN $102.19 -1.42 (-1.37%)
BioMarin Pharmaceutical Inc
BioMarin Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $92.75 which is 10.18% below the stock price of $102.19.
200 Day Moving Average
The 200 Day Moving Average is at 87.47 which is 16.83% below the stock price of $102.19.
Because both the 50 DMA and 200 DMA are below the current stock price, this can be considered a bullish technical indicator.
Since the stock price is very far from both moving averages, a price retracement towards the moving averages should not be unexpected.
BMRN Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $102.19.
The Year To Date (YTD) return is +12.26%.
52 Week Low
The 52 Week Low stock price is $75.81 set on Fri, Apr 6, 2018 which is 101 days ago.
The current price per share is 34.80% above the 52 week low.
52 Week High
The 52 Week High stock price is $104.00 set on Mon, Jul 16, 2018 which is Today. View all of today's 52 week highs.
The current price per share is -1.74% below the 52 week high.
All Time High
The All Time High stock price is $151.75 set on Mon, Jul 20, 2015 which is 1,092 days ago.
The current price per share is -32.66% below the all time high.
Below is the EPS, P/E Ratio and Earnings Date.
The EPS is -$0.84 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for BioMarin Pharmaceutical Inc was Thu, Feb 22, 2018.
Since this earnings release 144 days ago, the stock price is up by +21.35%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Wed, Apr 25, 2018, which was 82 days ago.
Since this earnings date, the stock price is up by +25.96%.
Below is important Dividend information.
BMRN currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.
Biotech & Pharma Industry
Below are other stocks in the same industry as BioMarin.
BMRN Company Profile
Learn more about BioMarin.
BioMarin Pharmaceutical Inc is a Health Care stock that trades on the NASDAQ and has a market capitalization of $18.31 Billion.
BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.
Spend a few minutes browsing the BioMarin Pharmaceutical Inc, web site at http://www.biomarinpharm.com.